A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
about
Optimal Use of Vaccines for Control of Influenza A Virus in SwineAttenuated Foot-and-Mouth Disease Virus RNA Carrying a Deletion in the 3' Noncoding Region Can Elicit Immunity in SwineClassical Swine Fever-An Updated ReviewPostnatal persistent infection with classical Swine Fever virus and its immunological implications.Efficacy of a live attenuated vaccine in classical swine fever virus postnatally persistently infected pigsClassical Swine Fever Virus vs. Classical Swine Fever Virus: The Superinfection Exclusion Phenomenon in Experimentally Infected Wild Boar.Nomenclature for factors of the swine leukocyte antigen class II system, 2005.Characterization and expression of e2 glycoprotein of classical Swine Fever virus in a eukaryotic expression system.Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza.Classical swine fever in pigs: recent developments and future perspectives.Co-expression of the C-terminal domain of Yersinia enterocolitica invasin enhances the efficacy of classical swine-fever-vectored vaccine based on human adenovirus.African swine fever virus infection in Classical swine fever subclinically infected wild boars.Control and eradication of Classic Swine Fever in wild boarAnimal health safety of fresh meat derived from pigs vaccinated against Classic Swine FeverMolecular characterization, expression and mapping of porcine LMP2 and MECL-1 genes.Association analysis of polymorphisms of porcine LMP2 and LMP7 genes with haematological traits.
P2860
Q26783503-F0C5A891-8E7D-4E07-AD73-44EFF97A473CQ27488277-07228FC1-85C5-4BD2-A2B7-16D106491FD5Q30234718-A4BE698E-5975-45D9-BA06-2E7F177CB1E5Q35566011-2B7209A8-3129-4EE7-87BB-73A6692CB891Q35834380-81C56534-7B15-43B1-BFD3-124AA2033B60Q35937619-CFB60AAA-31DE-4D01-8662-4FA8EBAFD090Q36321314-6C12565E-EEFA-45BC-BBA1-9DAE5C785458Q36550140-5D850E3B-7F07-4506-AFD7-9641E1F59DABQ37658883-1F4433B4-BC08-4873-B5B5-5B3C839ED9D6Q38326027-6444CFAF-5BD7-4B51-880E-D1F61B58D77FQ38903476-15393C59-F0C4-4291-9158-F0B1FDAE43E6Q40045137-5E77E977-0B7B-4FE3-88D8-FBE16FA503DAQ47146243-D161828B-D128-4274-8026-A5D24C422EB6Q47147214-7EFC0DD5-41DF-4F63-8AAB-876F6F9891ABQ48079139-99D868F6-0805-49CD-BF0B-90665BC97CD8Q50552275-B0965580-6778-431C-B808-BC0059ECDFD2
P2860
A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A DNA vaccine expressing the E ...... otection upon viral challenge.
@en
type
label
A DNA vaccine expressing the E ...... otection upon viral challenge.
@en
prefLabel
A DNA vaccine expressing the E ...... otection upon viral challenge.
@en
P2093
P50
P1433
P1476
A DNA vaccine expressing the E ...... rotection upon viral challenge
@en
P2093
Fernando Rodríguez
Isabel Blanco
Maritza Barrera
María Teresa Frias
P304
P356
10.1016/J.VACCINE.2005.01.153
P407
P577
2005-05-01T00:00:00Z